Efficacy of perindopril in reducing risk of cardiac events in patients with revascularized coronary artery disease
Open Access
- 30 April 2007
- journal article
- Published by Elsevier BV in American Heart Journal
- Vol. 153 (4), 629-635
- https://doi.org/10.1016/j.ahj.2007.01.032
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Optimizing management of patients with coronary artery disease: how do we get there?The opinions expressed in this article are not necessarily those of the Editors of the European Heart Journal or of the European Society of Cardiology.European Heart Journal, 2005
- ACE Inhibition in Stable Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: A review of randomized controlled trialsJournal of the American College of Cardiology, 2005
- Angiotensin-Converting–Enzyme Inhibition in Stable Coronary Artery DiseaseNew England Journal of Medicine, 2004
- Extended follow-up of patients randomly assigned in the angiotensin-converting enzyme inhibition post-revascularization study (APRES)American Heart Journal, 2004
- Secondary prevention after coronary artery bypass grafting – what do we know?Scandinavian Cardiovascular Journal, 2004
- ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)—executive summary: A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and InterventionsJournal of the American College of Cardiology, 2001
- Effects of quinapril on clinical outcome after coronary artery bypass grafting (the QUO VADIS study)The American Journal of Cardiology, 2001
- Myocardial infarction redefined—a consensus document of The Joint European Society of Cardiology/American College of Cardiology committee for the redefinition of myocardial infarctionJournal of the American College of Cardiology, 2000
- A Clinical Trial of the Angiotensin-Converting–Enzyme Inhibitor Trandolapril in Patients with Left Ventricular Dysfunction after Myocardial InfarctionNew England Journal of Medicine, 1995